Novacyt (FR:ALNOV) has released an update.
Novacyt S.A. has provided an update on its liquidity agreement with Invest Securities, revealing that 35,522 shares were bought and 29,221 were sold in October 2024. The company holds 82,311 treasury shares, while the total number of ordinary shares stands at 70,626,248. Novacyt continues to strengthen its position in the clinical diagnostics sector with a diverse range of molecular diagnostic products and services.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.
